Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment
Mengmeng Yang(China Pharmaceutical University), Lifang Yin(Jilin University), Nan Yang(Second Affiliated Hospital of Zhejiang University), Meirong Huo(China Pharmaceutical University), Fangnan Lv(China Pharmaceutical University), Xinyu Chu(Shanghai University of Engineering Science), Linlin Tao(China Pharmaceutical University), Gang Cheng(China Pharmaceutical University), Zuhang Xing(China Pharmaceutical University), Xiaopeng Han(Linyi University), Jingjing Li(Weifang Medical University), Chao Qin(Ludong University)
Cited by 66
Related Papers
High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance
|Nature Communications|2021|269
Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells
|ACS Nano|2018|229
Ultra-processed foods and human health: An umbrella review and updated meta-analyses of observational evidence
|Clinical Nutrition|2024|109
Cytosolic co-delivery of miRNA-34a and docetaxel with core-shell nanocarriers via caveolae-mediated pathway for the treatment of metastatic breast cancer
|Scientific Reports|2017|92
Nimodipine nanocrystals for oral bioavailability improvement: Role of mesenteric lymph transport in the oral absorption
|International Journal of Pharmaceutics|2013|87